{"id":71710,"date":"2023-08-17T11:39:34","date_gmt":"2023-08-17T06:09:34","guid":{"rendered":"http:\/\/finservwealth.com\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment\/"},"modified":"2023-08-17T11:39:34","modified_gmt":"2023-08-17T06:09:34","slug":"glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment\/","title":{"rendered":"Glenmark gets USFDA nod for generic Tacrolimus ointment"},"content":{"rendered":"<p> The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.<\/p><div id=\"finse-376627195\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment_17207091.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement. The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment_17207091.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment_17207091.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement. The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/glenmark-gets-usfda-nod-for-generic-tacrolimus-ointment_17207091.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The approval granted by the US Food  Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-71710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2019\/200x200\/G\/Glenmark-approved_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/71710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=71710"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/71710\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=71710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=71710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=71710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}